About Shaemus

A Journey in Radiopharmaceuticals

Shaemus Gleason is dedicated to providing specialized strategic guidance in the radiopharmaceutical healthcare sector.
He services clients including Global Pharmaceutical companies, private equity firms, and emerging businesses as well as partners with non-profit and industry thought leaders to advance the space. His mission is to drive increased adoption of radiopharmaceutical solutions and ultimately continue to improve patient outcomes.

Mission

Shaemus is on a mission to increase adoption and empower clients in the radiopharmaceutical industry through expert consulting and thought leadership. He aims to enhance operational efficiencies, foster innovation in drug or health imaging development, and leverage future-proofed commercial strategies for long term growth in the space. He strives to be a trusted partner in navigating the complexities of the healthcare landscape through the robust opportunities that radioisotope-based therapies and diagnostics offer. In doing so he transforms radiopharm potential into tangible performance.

Core Values

Integrity: Prioritizing honesty and transparency (not to mention a little fun)
in all ways, ensuring trust in my expertise and recommendations.

Partner-Centricity: All things done in partnership, whether with clients or collaborative organizations, to understand your unique challenges and deliver tailored solutions.

Innovation: Embracing innovation as a driving force, constantly seeking new ideas and methods to enhance the radiopharmaceutical space.

Current Engagements

Executive leadership and board member responsibilities. Note, no conflicting partnership opportunities will be taken with the following:

Clarity Pharmaceuticals

Executive Vice President since 2021

CORAR Board

Board Member for Council of Radiopharmaceutical Manufacturers since 2016

NRMAP Board

Executive Chairman, NIST National Radionuclide Measurement Assurance Program

Take the Next Step Towards Growth

INQUIRE TODAY